Reneo Pharmaceuticals, Inc. (RPHM)
Total Valuation
RPHM has a market cap or net worth of $55.30 million. The enterprise value is -$69.18 million.
Market Cap | 55.30M |
Enterprise Value | -69.18M |
Important Dates
The last earnings date was Thursday, March 28, 2024, before market open.
Earnings Date | Mar 28, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
RPHM has 33.31 million shares outstanding. The number of shares has increased by 38.01% in one year.
Shares Outstanding | 33.31M |
Shares Change (YoY) | +38.01% |
Shares Change (QoQ) | +11.89% |
Owned by Insiders (%) | 3.01% |
Owned by Institutions (%) | 82.41% |
Float | 14.65M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.48 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.49, with a Debt / Equity ratio of 0.01.
Current Ratio | 9.49 |
Quick Ratio | n/a |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -62.10% and return on invested capital (ROIC) is -62.55%.
Return on Equity (ROE) | -62.10% |
Return on Assets (ROA) | -55.60% |
Return on Capital (ROIC) | -62.55% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.23M |
Employee Count | 55 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.37% in the last 52 weeks. The beta is 0.24, so RPHM's price volatility has been lower than the market average.
Beta (1Y) | 0.24 |
52-Week Price Change | -69.37% |
50-Day Moving Average | 1.65 |
200-Day Moving Average | 5.07 |
Relative Strength Index (RSI) | 48.06 |
Average Volume (30 Days) | 356,068 |
Short Selling Information
The latest short interest is 2.82 million, so 8.48% of the outstanding shares have been sold short.
Short Interest | 2.82M |
Short Previous Month | 2.59M |
Short % of Shares Out | 8.48% |
Short % of Float | 19.28% |
Short Ratio (days to cover) | 12.01 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -72.61M |
Pretax Income | -67.43M |
Net Income | -67.43M |
EBITDA | -66.83M |
EBIT | -67.43M |
Earnings Per Share (EPS) | -$2.37 |
Balance Sheet
The company has $125.61 million in cash and $1.14 million in debt, giving a net cash position of $124.48 million or $3.74 per share.
Cash & Cash Equivalents | 125.61M |
Total Debt | 1.14M |
Net Cash | 124.48M |
Net Cash Per Share | $3.74 |
Equity / Book Value | 114.94M |
Book Value Per Share | 3.45 |
Working Capital | 115.21M |
Cash Flow
In the last 12 months, operating cash flow was -$59.54 million and capital expenditures -$446,000, giving a free cash flow of -$59.99 million.
Operating Cash Flow | -59.54M |
Capital Expenditures | -446,000 |
Free Cash Flow | -59.99M |
FCF Per Share | -$1.77 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
RPHM does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -38.01% |
Shareholder Yield | -38.01% |
Earnings Yield | -121.95% |
FCF Yield | -108.48% |
Analyst Forecast
The average price target for RPHM is $11.46, which is 590.36% higher than the current price. The consensus rating is "Buy".
Price Target | $11.46 |
Price Target Difference | 590.36% |
Analyst Consensus | Buy |
Analyst Count | 6 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |